EZH2 and breast carcinoma: We found that NBAT1 could inhibit the migration and invasion of breast cancer, while the effect of NBAT1 over-expression on invasion was reversed by concomitant EZH2 inhibitors, suggesting that the effect of NBAT1 on cell migration and invasion might be mediated through EZH2.